Skip to content
How It Works
Explore
Ask a Question Resources Pricing
Who It's For
Patients
Decode results, prep for appointments, weigh options.
Caregivers & advocates
Carry the research load for someone you love.
Providers & clinicians
Resources for patients in your practice.
Log In Sign Up
PubMed This is a summary of 21 peer-reviewed journal articles Updated
Neurology · Autoimmune Cerebellar Ataxia

Building Your Care Team & First Visit Prep

At a Glance

People with autoimmune cerebellar ataxia may benefit from coordinated care led by an autoimmune-neurology or movement-disorders specialist, with rehabilitation and oncology support when needed. Bring original scans, full antibody results, spinal tap records, and a symptom timeline.

Navigating autoimmune cerebellar ataxia (ACA) requires more than just a single neurologist; it requires a specialized team that understands the intersection of the immune system, the brain, and potentially, oncology. Because these conditions are rare and complex, your care team acts as a “safety net” to ensure every part of your health is monitored [1][2].

Building Your Multidisciplinary Team

A “hub-and-spoke” model is often best, where a specialized neurologist coordinates with other experts.

  • The Lead: Ataxia or Neuro-immunology Specialist: You need a neurologist who focuses specifically on autoimmune neurology or movement disorders. They are responsible for interpreting complex antibody tests and managing immunotherapies [3][1].
  • The Oncology Coordinator: If your antibodies suggest a paraneoplastic cause, a general medical oncologist or organ-specific oncologist (like a thoracic or gynecologic oncologist) is essential to coordinate with your neurologist in the search for an underlying tumor [4][5].
  • The Movement Experts: Physical (PT) and Occupational (OT) Therapists: Look for therapists who specialize in neuro-rehabilitation. They don’t just help with exercise; they teach you strategies to compensate for balance loss and keep you safe from falls [6][7].
  • The Communication Expert: Speech-Language Pathologist (SLP): An SLP is critical not just for slurred speech (dysarthria) but also for evaluating your swallowing safety (dysphagia) [8][9].

Your First Visit: The “Data Packet”

Specialists in rare diseases often find the most value in the “raw data” rather than a summary report from another doctor. To make your first visit productive, you should bring the following physical artifacts [10][11]:

1. Imaging Discs (Not Just Reports)

Bring the actual CD/DVD or digital access to your MRI, CT, and FDG-PET scans. Specialists often want to look at the “slices” of the cerebellum themselves to check for subtle shrinking (atrophy) or metabolic changes that a general radiologist might not highlight [10][12].

2. Complete Antibody Lab Reports

Do not settle for a note that says “Positive for GAD65.” You need the original lab printout that includes:

  • The Titer: The exact level or concentration of the antibody.
  • The Specimen Source: Whether it was found in the serum (blood), CSF (spinal fluid), or both [11][13].
  • The Methodology: The specific test used (e.g., “Cell-Based Assay” or “Immunoblot”) [14][15].

3. The Lumbar Puncture (Spinal Tap) Record

If you have already had a spinal tap, ensure you have the results for:

  • Oligoclonal Bands: And whether they were compared to your blood [16].
  • Cell Count and Protein: These show if there was active inflammation at the time of the test [17].

4. Comprehensive Medical History

Bring a timeline of your symptoms, a list of medications and supplements, your vaccination and infection history, and previous cancer screening records [18].

Vetting Your Specialist

Because ACA is rare, it is okay to ask your doctor about their experience. A qualified specialist should be comfortable using standardized tools like the SARA (Scale for the Assessment and Rating of Ataxia) to measure your progress objectively at every visit [19].

If your neurologist has only seen one or two cases in their career, they should be willing to consult with a referral center (such as an academic university hospital or a dedicated ataxia center) to confirm your treatment plan [1][20]. Coordinated care between your local doctor and a distant specialist is a common and effective way to manage these complex conditions [21][18].

Common questions in this guide

Which specialists should be on my autoimmune cerebellar ataxia care team?
A neurologist with autoimmune-neurology or movement-disorders experience can coordinate evaluation and treatment. Physical and occupational therapists can address balance and fall safety, a speech-language pathologist can assess speech and swallowing, and an oncologist may be involved if the antibody pattern suggests a paraneoplastic cause.
What should I bring to my first appointment for autoimmune cerebellar ataxia?
Bring the original MRI, CT, and FDG-PET files or digital access, along with the official reports. Also bring complete antibody and spinal tap results, a symptom timeline, a medication and supplement list, vaccination and infection history, and prior cancer screening records.
Why do specialists need the original MRI and PET files?
Reviewing the actual images lets a specialist examine individual brain slices for subtle cerebellar shrinkage or metabolic changes that may not be emphasized in a written report. Digital access is useful if physical discs are unavailable.
What details should be included in my autoimmune ataxia antibody report?
The report should show the antibody level or titer, whether the sample was blood, spinal fluid, or both, and which laboratory method was used. Examples of methods include a cell-based assay and an immunoblot.
How can I assess a neurologist’s experience with autoimmune ataxia?
Ask how many people with autoimmune or paraneoplastic ataxia they manage or advise each year and how they measure balance and coordination over time. A specialist should also be willing to consult an academic referral center or dedicated ataxia center when needed.
What rehabilitation support can help with autoimmune cerebellar ataxia?
A physical therapist can work on mobility, balance, and fall prevention, while an occupational therapist can teach safer ways to manage daily activities. A speech-language pathologist can help with slurred speech and evaluate whether swallowing is safe.
What other causes should be checked if I have autoimmune ataxia?
Adult-onset genetic ataxias, including FGF14 or RFC1 expansions, can sometimes resemble autoimmune ataxia, so ask whether genetic testing is appropriate. If the antibody profile suggests a paraneoplastic cause, cancer screening and follow-up may also be needed.

Questions For You

Answer a question to get research tailored to you. Your answers are private.

Get notified when new evidence is published on Non-specific autoimmune cerebellar ataxia with characteristic antibodies.

We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.

Questions to Ask Your Doctor

Curated prompts to bring to your next appointment.

  1. 1.How many patients with autoimmune or paraneoplastic ataxia do you personally manage or consult on each year?
  2. 2.Do you have a direct coordination process with a neuro-oncologist or an oncologist for cancer surveillance based on my antibody profile?
  3. 3.Can you personally review the original MRI and PET imaging files (not just the reports) to look for subtle cerebellar changes or metabolic signs?
  4. 4.Have we ruled out adult-onset genetic ataxias like the FGF14 or RFC1 expansions, which can look identical to autoimmune cases?
  5. 5.What standardized tool (like the SARA scale) do you use to track my balance and coordination over time?
  6. 6.Which specific speech-language pathologist and physical therapist do you recommend who have experience specifically with cerebellar disorders?

References

References (21)
  1. 1

    Causes of progressive cerebellar ataxia: prospective evaluation of 1500 patients.

    Hadjivassiliou M, Martindale J, Shanmugarajah P, et al.

    Journal of neurology, neurosurgery, and psychiatry 2017; (88(4)):301-309 doi:10.1136/jnnp-2016-314863.

    PMID: 27965395
  2. 2

    Consensus Paper: Neuroimmune Mechanisms of Cerebellar Ataxias.

    Mitoma H, Adhikari K, Aeschlimann D, et al.

    Cerebellum (London, England) 2016; (15(2)):213-32 doi:10.1007/s12311-015-0664-x.

    PMID: 25823827
  3. 3

    Update on Paraneoplastic Cerebellar Degeneration.

    Loehrer PA, Zieger L, Simon OJ

    Brain sciences 2021; (11(11)) doi:10.3390/brainsci11111414.

    PMID: 34827413
  4. 4

    Immune-mediated ataxias.

    Joubert B, Rostásy K, Honnorat J

    Handbook of clinical neurology 2018; (155()):313-332 doi:10.1016/B978-0-444-64189-2.00021-4.

    PMID: 29891069
  5. 5

    Immune-mediated Cerebellar Ataxias: Practical Guidelines and Therapeutic Challenges.

    Mitoma H, Manto M, Hampe CS

    Current neuropharmacology 2019; (17(1)):33-58 doi:10.2174/1570159X16666180917105033.

    PMID: 30221603
  6. 6

    [Adult-onset ataxias].

    Jacobi H, Minnerop M

    Der Nervenarzt 2021; (92(4)):379-389 doi:10.1007/s00115-021-01099-9.

    PMID: 33751151
  7. 7

    Long term clinical and neurophysiological effects of cerebellar transcranial direct current stimulation in patients with neurodegenerative ataxia.

    Benussi A, Dell'Era V, Cotelli MS, et al.

    Brain stimulation 2017; (10(2)):242-250 doi:10.1016/j.brs.2016.11.001.

    PMID: 27838276
  8. 8

    Immune Ataxias: The Continuum of Latent Ataxia, Primary Ataxia and Clinical Ataxia.

    Manto M, Mitoma H

    Journal of integrative neuroscience 2024; (23(4)):79 doi:10.31083/j.jin2304079.

    PMID: 38682229
  9. 9

    Evaluation of Cerebellar Ataxic Patients.

    Radmard S, Zesiewicz TA, Kuo SH

    Neurologic clinics 2023; (41(1)):21-44 doi:10.1016/j.ncl.2022.05.002.

    PMID: 36400556
  10. 10

    FDG-PET in Autoimmune Cerebellar Ataxia: Clinical Correlation and Diagnostic Superiority Over MRI.

    Liu M, Li Q, Mao G, et al.

    Cerebellum (London, England) 2025; (24(5)):130 doi:10.1007/s12311-025-01888-x.

    PMID: 40650847
  11. 11

    Autoimmune Movement Disorders.

    Balint B

    Continuum (Minneapolis, Minn.) 2024; (30(4)):1088-1109 doi:10.1212/CON.0000000000001455.

    PMID: 39088289
  12. 12

    Autoimmune Cerebellar Ataxia: Etiology and Clinical Characteristics of a Case Series from China.

    Liu M, Ren H, Zhu Y, et al.

    Cerebellum (London, England) 2023; (22(3)):379-385 doi:10.1007/s12311-022-01412-5.

    PMID: 35618871
  13. 13

    Clinical approach to neurological paraneoplastic syndromes.

    Anderson NE

    Internal medicine journal 2026; (56(8)):1314-1322 doi:10.1111/imj.70500.

    PMID: 42462243
  14. 14

    Diagnostic criteria for autoimmune encephalitis: utility and pitfalls for antibody-negative disease.

    Dalmau J, Graus F

    The Lancet. Neurology 2023; (22(6)):529-540 doi:10.1016/S1474-4422(23)00083-2.

    PMID: 37210100
  15. 15

    A case of Homer-3 IgG cerebellar ataxia & literature review of 15 reported cases.

    Anissian D, Dubey D, Vorasoot N, et al.

    Journal of neuroimmunology 2026; (412()):578846 doi:10.1016/j.jneuroim.2025.578846.

    PMID: 41453253
  16. 16

    Diagnostic Criteria for Primary Autoimmune Cerebellar Ataxia-Guidelines from an International Task Force on Immune-Mediated Cerebellar Ataxias.

    Hadjivassiliou M, Graus F, Honnorat J, et al.

    Cerebellum (London, England) 2020; (19(4)):605-610 doi:10.1007/s12311-020-01132-8.

    PMID: 32328884
  17. 17

    Oligoclonal bands: clinical utility and interpretation cues.

    Carta S, Ferraro D, Ferrari S, et al.

    Critical reviews in clinical laboratory sciences 2022; (59(6)):391-404 doi:10.1080/10408363.2022.2039591.

    PMID: 35277112
  18. 18

    Paraneoplastic Neurological Syndromes in Ovarian Cancer: Case Report and Narrative Review for Diagnostic and Clinical Implications.

    Restaino S, Gomba B, Golitsyna Y, et al.

    Healthcare (Basel, Switzerland) 2026; (14(13)) doi:10.3390/healthcare14131943.

    PMID: 42450953
  19. 19

    Clinical features and outcome of patients with autoimmune cerebellar ataxia evaluated with the Scale for the Assessment and Rating of Ataxia.

    Damato V, Papi C, Spagni G, et al.

    European journal of neurology 2022; (29(2)):564-572 doi:10.1111/ene.15161.

    PMID: 34710286
  20. 20

    Unravelling the etiology of sporadic late-onset cerebellar ataxia in a cohort of 205 patients: a prospective study.

    Bogdan T, Wirth T, Iosif A, et al.

    Journal of neurology 2022; (269(12)):6354-6365 doi:10.1007/s00415-022-11253-1.

    PMID: 35869996
  21. 21

    Paraneoplastic Neurological Syndromes: Advances and Future Perspectives in Immunopathogenesis and Management.

    Dimitrov S, Tsalta-Mladenov M, Kabakchieva P, et al.

    Antibodies (Basel, Switzerland) 2026; (15(1)) doi:10.3390/antib15010008.

    PMID: 41562781

This page is for informational purposes only and does not constitute medical advice. Your neurologist and specialist team should interpret your antibody, imaging, and spinal fluid results and tailor care to your situation.